Monthly Archives: May 2015

New guidance on data sharing published

New guidelines for how to share data from publicly funded clinical trials have gained the support of the UK Government’s health research funding body, the National Institute for Health Research (NIHR).

Data sharing makes clinical trials more useful to researchers. The contribution made by clinical trial participants can be put to greater use and unnecessary duplicate […]

28th May 2015|

Pharma company makes some trial data available: step in the right direction

Eisai Co., Ltd, a Japanese pharmaceutical company, has announced it is making some of its clinical trial data available to researchers through the external website

Eisai has said it will share clinical trial data only from trials of products approved after 1st January 2014, in Europe and the United States. This is the level of transparency that guidelines from industry bodies EFPIA and PhRMA recommend. Now, […]

28th May 2015|

Why a campaign to make medical studies public will help the global poor

Caroline Fiennes, Director of Giving Evidence, a charity that encourages charitable giving based on evidence, has written a great blog post that elegantly describes the problem of unpublished trials, and the positive impact the AllTrials campaign could have for the world’s poor.

Using a framework for analysing the impact of charities (impact = importance x idea x implementation), Caroline said:
“The importance […]

20th May 2015|

Company using court action to stop transparency

The Health Research Authority is facing a judicial review over its work to further clinical trial transparency, the Guardian reported today. The judicial review was launched in March by Richmond Pharmacology Ltd, a contract research organisation that runs clinical trials on behalf of pharmaceutical companies.

The Health Research Authority (HRA) is a UK body set up […]

18th May 2015|

The OPEN project recommendations on how to reduce publication bias in clinical research

The OPEN project brought together experts and academics from across Europe to address the issue of non-publication (or more broadly, non-dissemination) of clinical research findings. Results from clinical studies play an essential role in clinical decision making, and publication bias severely impacts the quality of this decision-making process. Between November 2011 and October 2013, the OPEN […]

13th May 2015|

The BMJ extends data sharing policy to all trials

The BMJ has announced that starting 1st July, researchers submitting any clinical trial to the journal will have to commit to making anonymised patient-level data available to independent researchers on reasonable request. Since January 2013, The BMJ has said that it would only publish clinical trials on drugs and medical devices from researchers who agreed […]

13th May 2015|

Watch Ben Goldacre: How can we get all trials reported?

With the World Health Organisation’s recent Statement on Public Disclosure of Clinical Trials Results, affirming that researchers have an ethical imperative to make results from all clinical trials publicly available, it is clear that we have made remarkable progress on the call for greater clinical trial transparency. However, as we have seen before, recognition of […]

1st May 2015|